ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,399.22
-0.51%
US Tech 100
18,550.40
1.20%
Dow Jones
39,935.07
0.00%
Brent Oil
81.085
-0.55%
Bitcoin
67,342.82
2.36%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Jpmorgan Multi-asset Growth & Income Plc (MATE) Quote

Jpmorgan Multi-asset Growth & Income Plc

Jpmorgan Multi-asset Growth & Income Plc (MATE)

Blockmate Ventures Inc
103.00
0.00
( 0.00% )
Updated: 20:00:00
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
103.00
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
86.00 52 Week Range 103.00
Market Cap
75.235M
Previous Close
103.00
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
73,043,408
Dividend Yield
5.73%
PE Ratio
-16.22
Earnings Per Share (EPS)
-0.06
Revenue
2.19M
Net Profit
-4.64M

About Jpmorgan Multi-asset Growth & Income Plc

Sector
Unit Inv Tr, Closed-end Mgmt
Industry
Unit Inv Tr, Closed-end Mgmt
Website
am.jpmorgan.com/gb/en/asset-management/institutional/products/jpmorgan-asia-growth-income-plc-ordinary-shares-gb0001320778
Headquarters
London, Gbr
Founded
1970
Jpmorgan Multi-asset Growth & Income Plc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the London Stock Exchange with ticker MATE. The last closing price for Jpmorgan Multi-asset Gro... was 103p. Over the last year, Jpmorgan Multi-asset Gro... shares have traded in a share price range of 86.00p to 103.00p.

Jpmorgan Multi-asset Gro... currently has 73,043,408 shares outstanding. The market capitalization of Jpmorgan Multi-asset Gro... is £75.23 million. Jpmorgan Multi-asset Gro... has a price to earnings ratio (PE ratio) of -16.22.

MATE Latest News

More News

London Stock Exchange Notice Cancellation - JPMORGAN MULTI-ASSET GRWTH & INCOME

London Stock Exchange Notice 27 March 2024   NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE   27/03/2024 - 08:00   At the request of the company the following...

March 27 2024
RNS Regulatory News

JPMorgan Multi-Asset Grwth & Income Result 2nd General Meeting & Scheme Entitlements

JPMorgan Multi-Asset Grwth & Income 26 March 2024   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM THE UNITED STATES OF AMERICA...

March 26 2024
RNS Regulatory News

JPMorgan Multi-Asset Grwth & Income Net Asset Value(s)

JPMorgan Multi-Asset Grwth & Income 26 March 2024   JPMORGAN MULTI-ASSET GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300C0UCY8X2QXW762 THE COMPANY ANNOUNCES THE...

March 26 2024
RNS Regulatory News

JPMorgan Multi-Asset Grwth & Income Gearing Announcement

JPMorgan Multi-Asset Grwth & Income 25 March 2024   JPMORGAN MULTI-ASSET GROWTH & INCOME PLC (the 'Company')   Inclusive of open exposure in Bond and Equity Index Futures Legal...

March 25 2024
RNS Regulatory News

JPMorgan Multi-Asset Grwth & Income Net Asset Value(s)

JPMorgan Multi-Asset Grwth & Income 25 March 2024   JPMORGAN MULTI-ASSET GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300C0UCY8X2QXW762 THE COMPANY ANNOUNCES THE...

March 25 2024
RNS Regulatory News

London Stock Exchange Notice Suspension - JPM Multi-Asset Growth & Income PLC

London Stock Exchange Notice 25 March 2024   NOTICE   25/03/2024 7:30am   TEMPORARY SUSPENSION OF TRADING ON MAIN MARKET - PREMIUM SEGMENT   JPMORGAN MULTI-ASSET GROWTH & INCOME PLC   At...

March 25 2024
RNS Regulatory News

JPMorgan Multi-Asset Grwth & Income Net Asset Value(s)

JPMorgan Multi-Asset Grwth & Income 22 March 2024   JPMORGAN MULTI-ASSET GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300C0UCY8X2QXW762 THE COMPANY ANNOUNCES THE...

March 22 2024
RNS Regulatory News

JPMorgan Multi-Asset Grwth & Income Net Asset Value(s)

JPMorgan Multi-Asset Grwth & Income 21 March 2024   JPMORGAN MULTI-ASSET GROWTH & INCOME PLC  (the 'Company')   Legal Entity Identifier: 549300C0UCY8X2QXW762 THE COMPANY ANNOUNCES THE...

March 21 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
266.256.4599483204196.7510396.758301298.87573252DE
5210.511.351351351492.5103866695594.69940372DE
156-0.5-0.48309178744103.5109865637698.07372994DE
2606.56.7357512953496.5109658989195.60218116DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WINTWindtree Therapeutics Inc
$ 6.68
(103.04%)
4.63M
CREVCarbon Revolution Public Ltd
$ 11.15
(80.71%)
2.67M
BFIBurgerFi International Inc
$ 0.3624
(70.06%)
10.86M
SLNASelina Hospitality PLC
$ 0.051
(35.64%)
70.71M
WATTEnergous Corporation
$ 0.9936
(25.19%)
124
DXCMDexCom Inc
$ 66.90
(-37.97%)
533.09k
NMHINatures Miracle Holding Inc
$ 0.27
(-31.09%)
789.82k
ADNAdvent Technologies Holdings Inc
$ 3.50
(-28.57%)
11.48k
ZYXIZynex Inc
$ 7.83
(-23.16%)
1.98k
RENBRenovaro Inc
$ 1.02
(-18.40%)
137
SLNASelina Hospitality PLC
$ 0.051
(35.64%)
70.71M
VWEVintage Wine Estates Inc
$ 0.0859
(22.89%)
14.23M
BFIBurgerFi International Inc
$ 0.3624
(70.06%)
10.86M
WINTWindtree Therapeutics Inc
$ 6.68
(103.04%)
4.63M
SYTASiyata Mobile Inc
$ 0.5505
(17.63%)
4.19M

Discussion

View Full Feed
Jetmek_03052 Jetmek_03052 2 minutes ago
What a completely ridiculous statement:

funding is to grow company

Point out the "growth" and how this "growth" is helping the investors of this company!

CLEARLY, there is NO GROWTH! The company is getting deeper and DEEPER into DEBT EVERY QUARTER. Th
DBMM
domainmaster domainmaster 3 minutes ago
Whenever Jasson Domínguez returns I doubt anyone will be complaining about Alex Verdugo losing playing time.

With Giancarlo Stanton close to returning Soto, Judge, Domínguez and Stanton adds much more pizazz than Soto, Judge and the "Magnificent Seven".
Cordova1947 Cordova1947 3 minutes ago
https://mail.google.com/mail/u/0/?tab=rm&ogbl#inbox/FMfcgzQVxlQDDRvbvnBsRFMzKrPBRBCP
AXXA
learningcurve2020 learningcurve2020 3 minutes ago
You and the others suffer from some odd form confirmation bias. Bizarre.
NWBO
oystersnbeer oystersnbeer 3 minutes ago
https://x.com/KamalaHQ/status/1816641652510822681
m0n m0n 4 minutes ago
14 years going 15! LoL. Can’t wait for the next Q to see what the 2024 awareness campaign did in terms of sales LoL.

$36,000 in gross sales thus far.

7 figures in deficits that continue to grow.

14 years of operating in the RED w/ a $51 milly market cap?
IFUS
TheFinalCD TheFinalCD 4 minutes ago
https://x.com/TyroneLopez_/status/1816801231773544484
SLNA
mike_dotcom mike_dotcom 4 minutes ago
No brain swelling, no brain bleeding, no costly MRIs, and stoppage of brain shrinking with blarcamesine - it's a NO BRAINER.
AVXL
hope4patients hope4patients 5 minutes ago
The experts refer to Dcvax as a “breakthrough” with “astonishing” results but please continue to spew your anonymous nonsense 24/7. I prefer the non-anonymous expert opinions. Citations below :)

https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/

https://br
NWBO
cintrix cintrix 5 minutes ago
ZYXI down 24% on earnings miss and outlook cut
jeunke22 jeunke22 5 minutes ago
The upward value potential of LWLG is indeed very substantial.
What I wonder is how the small handful of market makers are going to get rid of close to 20 mio uncovered shares ?
For a company like Citadel taking a loss on LWLG is like rounding off their profit numbers to full decimal
LWLG
mikepgator mikepgator 5 minutes ago
Nice!
COOP
hnbadger1 hnbadger1 6 minutes ago
Thanks for sharing sokol! That certainly bolds well for Anavex!
It’s almost as if they know something better is going to be approved soon!😉
AVXL
redspeed redspeed 6 minutes ago
Toast...

"We are filing this registration statement with the Securities and Exchange Commission (the “SEC”) using a “shelf” registration process. Under this registered “shelf,” in the future, we may, from time to time, sell any combination of the securities described herein, in one
IBIO
StealthyVoyager80 StealthyVoyager80 6 minutes ago
Listen here you jobless bashers from the trailer park. You post here because you can't afford any shares you are broke and jealous. Ilus will be a billion dollar company soon!
ILUS
lovethatgreen lovethatgreen 7 minutes ago
After 2.6 years prep w interactive communication with the fda

Working side by side with them John Hopkins and Mayo scheduled to do human trials
And the BDD

Disapproval w require a flaw in the requested data
Working with the stated agencies combined with
RDGL
WeTheMarket WeTheMarket 7 minutes ago
DWC, you conveniently neglected to mention the rise in revenues, which one could argue has been more consistent than the rise in share count, as they had a 10:1 reverse split in 2011 which reduced the share count by a factor of 10.
PLUG
rikkie rikkie 7 minutes ago
Do you have shares?
LWLG
stock1ace1 stock1ace1 7 minutes ago
Sxtc $1.19s HOD if breaks here could fly
Twilson Twilson 7 minutes ago
Looks like puts will get punished at open
jjtcwine jjtcwine 7 minutes ago
$ZPTA Michael Andretti purshased 15% stake!
ZPTA
mascale mascale 8 minutes ago
Then mining bonus remains intact, OTCMG!
HIRU
mike_dotcom mike_dotcom 8 minutes ago
Biogen Shares Down Pre-Bell After European Committee Adopts Negative Opinion on Alzheimer's Treatment
AVXL

Your Recent History

LSE
MATE
Jpmorgan Multi-asset Gro...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved